Sumary of World Health Organization Rejects Remdesivir, The Antiviral Trump Took For Covid-19, Saying There’s No Evidence It Helps Recovery Or Survival:
- Topline The World Health Organization (WHO) has recommended against using one of the only drugs approved to treat Covid-19 around the world, saying it has found no evidence to suggest that Gilead remdesivir helps hospitalized patients recover or improves their outcomes..
- getty Key Facts An expert WHO panel said Friday that it does not recommend remdesivir for any patients hospitalized with Covid-19, no matter how sick they are, as there is no evidence the drug will help or improve patient outcomes..
- The panel “found a lack of evidence that remdesivir improved outcomes that matter to patients such as reduced mortality, need for mechanical ventilation, time to clinical improvement, and others,”.
- The advice, which was based on a review of evidence including data from four international trials covering more than 7,000 hospitalized Covid-19 patients, was published in the British Medical Journal as part of the group “living guideline,”.
- The panel emphasized that their advice doesn’t mean remdesivir has no benefit, just that there is no evidence suggesting that it improves outcomes important to patients, especially given the fact that remdesivir is expensive and must be administered intravenously..
- The new advice follows a major WHO-run trial that determined remdesivir to have little effect in preventing Covid-19 deaths, something the manufacturer Gilead strongly contested..
- Key Background In the early stages of the pandemic, remdesivir, which maker Gilead markets as Veklury, was a source of hope for many….